Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Periodic Reporting for period 2 - INSPIRE (INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.)

Reporting period: 2022-01-01 to 2024-05-31

INSPIRE has created a long-lasting impact on the field of Safety Pharmacology
My booklet 0 0